Monday, November 30, 2015

The Future of Biotech Enterprise: Exponential Opportunities and Existential Risks



The future of biotechnology has many opportunities to create abundance, but also many risks for destruction. Dmitry Kaminskiy will be speaking with Professors Chris Lowe and Derek Smith about exponential opportunities and existential risks. This is certain to be a valuable and enlightening discussion!



Bioscience technologies have the power to build or destroy a world of health and abundance. Leveraging entrepreneurial opportunities whilst avoiding catastrophic risk is a balancing act with potentially fatal consequences.

Guest Speakers include:

Professor Chris Lowe OBE, FREng, FInstP, FRSC
- Emeritus Professor, Chemical Engineering and Biotechnology, University of Cambridge
- Awarded ‘most entrepreneurial scientist in the UK’, with research recognised by over 20 major national and international awards

Professor Derek Smith
- Professor of Infectious Disease Informatics, University of Cambridge
- Director of WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases

Dmitry Kaminskiy
- Founder and investor of Deep Knowledge Ventures, Deep Knowledge Life Sciences, OncoFinder, Insilico Medicine, Exponential Technologies Institute, and iBank.
- Developer of artificial intelligence systems VITAL, and SPOCK. Director of the Biogerontology Research Foundation

Refreshments will be provided after the talk.

Sponsored by: Deep Knowledge Ventures - Life Sciences, and BGRF

In collaboration with: Cambridge University Entrepreneurs, Centre for the Study of Existential Risk, Centre for the Advancement of Sustainable Medical Innovation, and Cambridge University Department of Chemical Engineering and Biotechnology


The event will take place on  december 2 in The Queen's Lecture Theatre, Emmanuel College, Cambridge. 

Friday, November 20, 2015

Beauty.AI Announces the First International Beauty Contest Judged by an Artificial Intelligence Jury

In a move that will enter into the history books as the first beauty contest judged by artificial intelligence, Beauty.AI opens as a platform bridging human participants and algorithm developers with a mission to develop an impartial machine intelligence with the perception of human beauty. People are able to enter the beauty pageant using a mobile app, and data scientists teams from all over the world can submit algorithms for evaluating the many criteria linked to perception of human beauty, "youthfulness", and health.


What matters in beauty is perception. Perception is how you and other people see you, and this perception is almost always biased. Still, healthy people look more attractive despite their age and nationality.
This has enabled the team of biogerontologists and data scientists, who believe that in the near future machines will be able to get a lot of vital medical information about people's health by just processing their photos, to develop a set of algorithms that can accurately evaluate the criteria linked to perception of human beauty and health where it is most important – the human face. But evaluating beauty and health is not enough. The team’s challenge is to find effective ways to slow down ageing and help people look healthy and beautiful.

As a first step to this ambitious challenge, the team has started the huge international scientific experiment, called The First Beauty Contest Judged by Artificial Intelligence, where they invite all the people of the world, including the Robot Jury - Data Scientists, who will teach machines to estimate human attractiveness.
Robots will look at human pictures taken by a standardized app and compare them with millions of others. They will evaluate the many features including symmetry, skin color, wrinkles and many other beauty, youthfulness and health parameters which affect our perception of human beauty and rank people within their age group, race and gender. 

“Artificial intelligence systems have already surpassed humans in image recognition, and it is only a matter of time before robots will be able to evaluate human visual appeal, engage in fashion design, and even make perfumes. We decided to build a platform which will help bridge some of the most advanced humans - those who are interested in robot opinion and those developers, who are building intelligent systems to understand the beauty function. We want to turn this into a quarterly contest, which will attract more algorithms and more people interested in getting an impartial perception of their beauty, taking into consideration their age, gender and thousands of other parameters”, said Alexey Shevtsov, the co-founder of Youth Laboratories collective. This ambitious team has also partnered with top infrastructural companies like Nvidia and Microsoft to provide the best computation facilities for algorithm testing. 

This contest also provides several opportunities to go down in human history: as the first human in the world to win the the beauty contest judged by robots, or as one of the first data scientists who taught a machine to estimate human attractiveness.

“Most people are not interested in aging or in extending longevity, but they are interested in how others perceive their appearance. My interest in Beauty.AI is related to understanding how the perception of someone’s facial appearance changes with age. Humans are generally biased and there needs to be a robot to provide an impartial opinion. Beauty.AI is the first step in a much larger story, in which a mobile app trained to evaluate the perception of human appearance will evolve into a caring personal assistant to help users look their best and retain their youthful looks for as long as possible”, said Alex Zhavoronkov, PhD, CEO of Insilco Medicine, Inc, who consults on aging and age-related issues.

The Beauty.AI contest will be conducted online at http://www.beauty.ai
It’s timeline is: It starts as of November, 19, 2015, All people of the world are welcome to submit their selfies up to January, 15, 2016 through the Beauty.AI App, Data scientists teams are welcome to submit their algorithms up to January, 20, 2016 on http://www.beauty.ai, 
Winners will be announced as of January, 28, 2016.

The Beauty.AI mobile app for Android platforms is available for download today and the iPhone mobile app will become available in four weeks after the launch date. 


About Beauty.AI 

Beauty.AI is the first beauty contest judged entirely by robot jury, where humans and robots can apply participate. Every quarter this platform will open submissions for multiple developers of beauty-ranking algorithms to train and test their systems. The project is organized by the Youth Laboratories collective, which is dedicated to understanding of the human nature and effective ways to slow down aging and retain the youthful look for as long as possible.
If you have any questions about the science of aging, bioinformatics, deep learning or Youth Laboratories collective’s plan for larger story, please email to team@beauty.ai or visit: http://www.beauty.ai

Sunday, November 15, 2015

Oncotech 2015 conference

Hello world! Just want to share the information about top and promising conference in Russia:
Oncotech 2015 conference. The conference was going 12 November in Moscow and was devoted to solutions of temporary problems in oncodiagnostic and also for analisis Big biomedical data in oncology. On  this event IBM and the First Oncology Research and Clinical Center discussed the applications of the Watson and OncoFinder systems in clinical oncology. OncoFinder' team introduced to top Russian oncologists pricipals of #OncoFinder system work.

Conference speakers were Alexandr Rumyancev, Anton Budzin, Elena Poddubskaya, Andrey Garaga, Pavel Shkudov, Pavel Spirin, Nikolay Zhukov and Michael Wirth.
 I hope, that this new tech solutions in oncology can save many oncology patient lifes! Good luck!

Also you may see here the program of this #Oncotech 2015 conference

Tuesday, November 10, 2015

Is aging a disease? Scientists call for new classification of aging

In a paper recently published in Frontiers in Genetics, scientists at Insilco Medicine highlight the need for more granular and applied classification of aging in the context of the 11th World Health Organization's (WHO) International Statistical Classification of Diseases and Related Health Problems (ICD-11) expected to be finalized in 2018.

The paper explores the evolution of disease classification practices and the progress made since William Cullen's seminal Nosolagae Methodicae synopsis published in 1769. It discusses some of the additions to the ICD-10 including some of the less obvious conditions like obesity that may set the precedent for classifying aging as a disease.

While there is clear disagreement among demographers, gerontologists and biogerontologists on the subject, classification of aging as a disease is likely to unite both scientists and medical practitioners in the effort to prevent the pathological age-related processes and attract more resources to aging research.

In part, the report calls for creating a task force of scientists to more thoroughly evaluate whether to provide a more granular and actionable classification of aging as a disease in ICD-11.

"Aging is a complex multifactorial process leading to loss of function and a very broad spectrum of diseases. While the notion of whether aging itself is a disease is usually disputed, classifying it as such will help shift the focus of biomedicine from treatment to prevention. Classifying aging as a disease with multiple 'non-garbage' ICD codes may help create business cases for large pharmaceutical companies to focus more R&D resources on this important field. Considering the unprecedented increases in life expectancy and the heavy burden of medical costs in the developed countries, maintaining the human body in the disease-free youthful state for as long as possible is not just an altruistic cause, but a pressing economic necessity", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine, Inc.

The paper is available online via the Frontiers open access system at http://journal.frontiersin.org/article/10.3389/fgene.2015.00326/abstract

Paper citation: 

Zhavoronkov A and Bhullar B (2015) Classifying aging as a disease in the context of ICD-11. Front. Genet. 6:326. doi: 10.3389/fgene.2015.00326

About Insilico Medicine Inc.
 
Insilico Medicine Inc. is a Baltimore-based company utilizing advances in deep learning and big data analysis for in silico drug discovery and drug repurposing for aging and age-related diseases. The company utilizes the GeroScope(TM), OncoFinder(TM), Pathway Cloud Intelligence(TM) and PharmAtlas(TM) packages for aging and cancer research, pursues internal drug discovery programs, and provides services to pharmaceutical companies and academic institutions.

For more information on Insilico Medicine's use of NVIDIA GPU Technology, please visit: http://goo.gl/u3J0CF. For the conference soundtrack, please visit http://goo.gl/QqkJXT.

Media Contact:
Qingsong Zhu
qszhu2000@gmail.com
410-710-9674